Showing results (491-500 of 590) with videos related to
Sort By:
Pageof 59
Journal of Molecular Biology|November 19, 2011
Molecular basis for the activation of a catalytic asparagine residue in a self-cleaving bacterial autotransporterTravis J Barnard, James Gumbart, Janine H Peterson, et al.Blood|May 26, 1999
Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugateE L Sievers, F R Appelbaum, R T Spielberger, et al.Blood|July 1, 1989
Interleukin-3, GM-CSF, and G-CSF receptor expression on cell lines and primary leukemia cells: receptor heterogeneity and relationship to growth factor responsivenessL S Park, P E Waldron, D Friend, et al.The Lancet. Haematology|July 5, 2016
Infusion of a non-HLA-matched ex-vivo expanded cord blood progenitor cell product after intensive acute myeloid leukaemia chemotherapy: a phase 1 trialColleen Delaney, Filippo Milano, Laura Cicconi, et al.Blood|October 15, 1991
Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primatesR G Andrews, G H Knitter, S H Bartelmez, et al.Nature Communications|April 19, 2025
Angle-controllable RNA tiles for programable array assembly and RNA sensingQi Yang, Xu Chang, Jung Yeon Lee, et al.Cancer Research|January 1, 1992
Localization of radiolabeled antimyeloid antibodies in a human acute leukemia xenograft tumor modelR H van der Jagt, C C Badger, F R Appelbaum, et al.Journal of Viral Hepatitis|September 1, 1996
Hepatitis C virus RNA quantification in right and left lobes of the liver in patients with chronic hepatitis CV Idrovo, P J Dailey, L J Jeffers, et al.Blood|July 1, 2006
FLT3 internal tandem duplication in CD34+/CD33- precursors predicts poor outcome in acute myeloid leukemiaJessica A Pollard, Todd A Alonzo, Robert B Gerbing, et al.Cytotherapy|January 7, 2015
Notch ligand Delta-like 1 promotes in vivo vasculogenesis in human cord blood-derived endothelial colony forming cellsHyojin Kim, Lan Huang, Paul J Critser, et al.Pageof 59